nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenobarbital—CHRFAM7A—corpus luteum—ovarian cancer	0.222	0.246	CbGeAlD
Methylphenobarbital—CHRNA7—corpus luteum—ovarian cancer	0.179	0.199	CbGeAlD
Methylphenobarbital—CHRFAM7A—ovarian follicle—ovarian cancer	0.174	0.192	CbGeAlD
Methylphenobarbital—CHRNA7—ovarian follicle—ovarian cancer	0.14	0.155	CbGeAlD
Methylphenobarbital—GRIA2—embryo—ovarian cancer	0.0258	0.0285	CbGeAlD
Methylphenobarbital—CHRFAM7A—female reproductive system—ovarian cancer	0.0142	0.0158	CbGeAlD
Methylphenobarbital—CHRFAM7A—female gonad—ovarian cancer	0.013	0.0143	CbGeAlD
Methylphenobarbital—CHRNA7—uterus—ovarian cancer	0.0128	0.0142	CbGeAlD
Methylphenobarbital—GRIA2—testis—ovarian cancer	0.0126	0.014	CbGeAlD
Methylphenobarbital—GABRA5—testis—ovarian cancer	0.0118	0.0131	CbGeAlD
Methylphenobarbital—CHRNA7—female reproductive system—ovarian cancer	0.0115	0.0127	CbGeAlD
Methylphenobarbital—CHRFAM7A—testis—ovarian cancer	0.0115	0.0127	CbGeAlD
Methylphenobarbital—GABRA3—testis—ovarian cancer	0.011	0.0122	CbGeAlD
Methylphenobarbital—CHRNA7—female gonad—ovarian cancer	0.0105	0.0116	CbGeAlD
Methylphenobarbital—CHRNA7—testis—ovarian cancer	0.00929	0.0103	CbGeAlD
Methylphenobarbital—GABRA2—vagina—ovarian cancer	0.00919	0.0102	CbGeAlD
Methylphenobarbital—GRIA2—Trafficking of GluR2-containing AMPA receptors—NSF—ovarian cancer	0.00827	0.088	CbGpPWpGaD
Methylphenobarbital—CYP2C19—vagina—ovarian cancer	0.00669	0.0074	CbGeAlD
Methylphenobarbital—CYP2B6—gonad—ovarian cancer	0.00648	0.00717	CbGeAlD
Methylphenobarbital—GABRA2—lymph node—ovarian cancer	0.00594	0.00658	CbGeAlD
Methylphenobarbital—CYP2B6—female reproductive system—ovarian cancer	0.00579	0.00641	CbGeAlD
Methylphenobarbital—CYP2B6—vagina—ovarian cancer	0.00524	0.00579	CbGeAlD
Methylphenobarbital—GRIA2—Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity—NSF—ovarian cancer	0.005	0.0532	CbGpPWpGaD
Methylphenobarbital—CYP2B6—testis—ovarian cancer	0.00467	0.00517	CbGeAlD
Methylphenobarbital—CYP2B6—Liver X Receptor Pathway—FASN—ovarian cancer	0.00229	0.0243	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.00191	0.0203	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—ovarian cancer	0.00188	0.02	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.00174	0.0185	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—ovarian cancer	0.00171	0.0182	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.00146	0.0155	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—NSF—ovarian cancer	0.00143	0.0152	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—NSF—ovarian cancer	0.00143	0.0152	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.00141	0.015	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—NSF—ovarian cancer	0.0013	0.0139	CbGpPWpGaD
Methylphenobarbital—Phenobarbital—CYP1B1—ovarian cancer	0.00129	0.63	CrCbGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.00121	0.0129	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.0012	0.0127	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—NSF—ovarian cancer	0.0011	0.0117	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—NSF—ovarian cancer	0.0011	0.0117	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.00106	0.0113	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—NSF—ovarian cancer	0.00106	0.0113	CbGpPWpGaD
Methylphenobarbital—GABRA6—Orphan transporters—TUBB3—ovarian cancer	0.00105	0.0112	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.00105	0.0111	CbGpPWpGaD
Methylphenobarbital—GABRA4—Orphan transporters—TUBB3—ovarian cancer	0.00104	0.0111	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.00103	0.0109	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—NSF—ovarian cancer	0.001	0.0106	CbGpPWpGaD
Methylphenobarbital—GABRA6—Ion channel transport—ATP7B—ovarian cancer	0.000936	0.00995	CbGpPWpGaD
Methylphenobarbital—GABRA5—Orphan transporters—TUBB3—ovarian cancer	0.000925	0.00984	CbGpPWpGaD
Methylphenobarbital—GABRA4—Ion channel transport—ATP7B—ovarian cancer	0.000924	0.00983	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000912	0.0097	CbGpPWpGaD
Methylphenobarbital—GABRA3—Orphan transporters—TUBB3—ovarian cancer	0.000909	0.00966	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—NSF—ovarian cancer	0.0009	0.00958	CbGpPWpGaD
Methylphenobarbital—GABRA2—Orphan transporters—TUBB3—ovarian cancer	0.000893	0.0095	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NSF—ovarian cancer	0.000876	0.00931	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Tamoxifen metabolism—CYP1B1—ovarian cancer	0.000869	0.00924	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—NSF—ovarian cancer	0.00084	0.00893	CbGpPWpGaD
Methylphenobarbital—GABRA5—Ion channel transport—ATP7B—ovarian cancer	0.000821	0.00873	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—NSF—ovarian cancer	0.000815	0.00866	CbGpPWpGaD
Methylphenobarbital—GABRA3—Ion channel transport—ATP7B—ovarian cancer	0.000806	0.00857	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—NSF—ovarian cancer	0.0008	0.00851	CbGpPWpGaD
Methylphenobarbital—GABRA2—Ion channel transport—ATP7B—ovarian cancer	0.000792	0.00843	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000786	0.00835	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000772	0.00821	CbGpPWpGaD
Methylphenobarbital—GABRA1—Orphan transporters—TUBB3—ovarian cancer	0.000761	0.0081	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—IKBKG—ovarian cancer	0.000758	0.00806	CbGpPWpGaD
Methylphenobarbital—GRIA2—N-cadherin signaling events—CTNNB1—ovarian cancer	0.000738	0.00785	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—NSF—ovarian cancer	0.000699	0.00743	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—NSF—ovarian cancer	0.00069	0.00734	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000676	0.00719	CbGpPWpGaD
Methylphenobarbital—GABRA1—Ion channel transport—ATP7B—ovarian cancer	0.000676	0.00719	CbGpPWpGaD
Methylphenobarbital—GRIA2—Hypothetical Network for Drug Addiction—MAPK3—ovarian cancer	0.000676	0.00718	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Melatonin metabolism and effects—CYP1B1—ovarian cancer	0.000671	0.00714	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—NSF—ovarian cancer	0.000658	0.007	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	0.000644	0.00685	CbGpPWpGaD
Methylphenobarbital—GRIA2—Hypothetical Network for Drug Addiction—MAPK1—ovarian cancer	0.000643	0.00683	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—NSF—ovarian cancer	0.000613	0.00652	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—NSF—ovarian cancer	0.000602	0.0064	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—NSF—ovarian cancer	0.000592	0.00629	CbGpPWpGaD
Methylphenobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—ovarian cancer	0.000527	0.00561	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	0.000511	0.00543	CbGpPWpGaD
Methylphenobarbital—GRIA2—N-cadherin signaling events—PIK3CA—ovarian cancer	0.000508	0.0054	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—NSF—ovarian cancer	0.000504	0.00536	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000497	0.00528	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00049	0.00521	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Arachidonic acid metabolism—CYP1B1—ovarian cancer	0.000434	0.00462	CbGpPWpGaD
Methylphenobarbital—GRIA2—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—ovarian cancer	0.000423	0.0045	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000403	0.00428	CbGpPWpGaD
Methylphenobarbital—Phenytoin—ABCB1—ovarian cancer	0.000386	0.189	CrCbGaD
Methylphenobarbital—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	0.000375	0.00399	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	0.00037	0.00394	CbGpPWpGaD
Methylphenobarbital—Phenobarbital—ABCB1—ovarian cancer	0.00037	0.181	CrCbGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—APC—ovarian cancer	0.000358	0.00381	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.00034	0.00361	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000335	0.00357	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000326	0.00346	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000322	0.00342	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000304	0.00324	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000298	0.00317	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000295	0.00313	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000293	0.00311	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000288	0.00306	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000286	0.00304	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000282	0.003	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000281	0.00298	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000276	0.00293	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—MTOR—ovarian cancer	0.000275	0.00292	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000272	0.00289	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000258	0.00274	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000257	0.00274	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000254	0.0027	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—CASP3—ovarian cancer	0.000253	0.00269	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—AQP3—ovarian cancer	0.000245	0.00261	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—CTNNB1—ovarian cancer	0.000244	0.00259	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.00024	0.00255	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000239	0.00254	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ATP7B—ovarian cancer	0.000235	0.0025	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000235	0.0025	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.00023	0.00244	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000226	0.0024	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000222	0.00236	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000222	0.00236	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000218	0.00232	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Biological oxidations—CYP1B1—ovarian cancer	0.000214	0.00227	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—STAT3—ovarian cancer	0.000212	0.00226	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000211	0.00224	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000207	0.0022	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—MAPK3—ovarian cancer	0.000203	0.00216	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000197	0.0021	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000195	0.00207	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000194	0.00206	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—MAPK1—ovarian cancer	0.000193	0.00205	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000191	0.00204	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000189	0.002	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000186	0.00198	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000177	0.00188	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000172	0.00183	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.00017	0.0018	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000166	0.00176	CbGpPWpGaD
Methylphenobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000165	0.00176	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000164	0.00175	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000164	0.00174	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000162	0.00172	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Biological oxidations—CYP1B1—ovarian cancer	0.000162	0.00172	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000159	0.0017	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000158	0.00168	CbGpPWpGaD
Methylphenobarbital—GRIK2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000156	0.00166	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—HRAS—ovarian cancer	0.000155	0.00165	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000154	0.00163	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000151	0.0016	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—MAPK1—ovarian cancer	0.000149	0.00158	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—CXCL8—ovarian cancer	0.000149	0.00158	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000148	0.00158	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000148	0.00157	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000146	0.00155	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000145	0.00155	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000144	0.00153	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000144	0.00153	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000143	0.00152	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—ovarian cancer	0.000142	0.00151	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000142	0.00151	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000141	0.0015	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00014	0.00149	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000139	0.00148	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—CTNNB1—ovarian cancer	0.000137	0.00146	CbGpPWpGaD
Methylphenobarbital—GRIA2—BDNF signaling pathway—AKT1—ovarian cancer	0.000137	0.00145	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—MAPK1—ovarian cancer	0.000135	0.00144	CbGpPWpGaD
Methylphenobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—ovarian cancer	0.000135	0.00143	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000132	0.0014	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000131	0.00139	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—NME2—ovarian cancer	0.00013	0.00139	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.00013	0.00138	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000129	0.00138	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000125	0.00133	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000124	0.00132	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000123	0.00131	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000122	0.0013	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—VEGFA—ovarian cancer	0.000121	0.00128	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.00012	0.00127	CbGpPWpGaD
Methylphenobarbital—GRIK2—Neuronal System—HRAS—ovarian cancer	0.000119	0.00127	CbGpPWpGaD
Methylphenobarbital—GRIA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000119	0.00127	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—ovarian cancer	0.000119	0.00126	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000116	0.00123	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	0.000116	0.00123	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000115	0.00122	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—MAPK1—ovarian cancer	0.000114	0.00121	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000114	0.00121	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000113	0.0012	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	0.000112	0.00119	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000111	0.00118	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—MAPK1—ovarian cancer	0.00011	0.00117	CbGpPWpGaD
Methylphenobarbital—CHRNA7—Neuronal System—HRAS—ovarian cancer	0.000109	0.00115	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000108	0.00115	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000106	0.00113	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—MAPK1—ovarian cancer	0.000104	0.00111	CbGpPWpGaD
Methylphenobarbital—GABRA6—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.91e-05	0.00105	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—NME2—ovarian cancer	9.86e-05	0.00105	CbGpPWpGaD
Methylphenobarbital—GABRA4—Transmission across Chemical Synapses—HRAS—ovarian cancer	9.78e-05	0.00104	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ovarian cancer	9.51e-05	0.00101	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—ovarian cancer	9.46e-05	0.00101	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—MAPK1—ovarian cancer	9.45e-05	0.00101	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—MAPK1—ovarian cancer	9.34e-05	0.000993	CbGpPWpGaD
Methylphenobarbital—GRIA2—Neuronal System—HRAS—ovarian cancer	9.13e-05	0.00097	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—MAPK1—ovarian cancer	8.91e-05	0.000947	CbGpPWpGaD
Methylphenobarbital—CHRNA4—Neuronal System—HRAS—ovarian cancer	8.85e-05	0.000941	CbGpPWpGaD
Methylphenobarbital—GABRA5—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.69e-05	0.000924	CbGpPWpGaD
Methylphenobarbital—GABRA3—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.53e-05	0.000908	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYTB—ovarian cancer	8.4e-05	0.000894	CbGpPWpGaD
Methylphenobarbital—GABRA2—Transmission across Chemical Synapses—HRAS—ovarian cancer	8.39e-05	0.000892	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	8.36e-05	0.000889	CbGpPWpGaD
Methylphenobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—ovarian cancer	8.35e-05	0.000888	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—MAPK1—ovarian cancer	8.29e-05	0.000882	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—MAPK1—ovarian cancer	8.15e-05	0.000866	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—MAPK1—ovarian cancer	8e-05	0.000851	CbGpPWpGaD
Methylphenobarbital—GABRA6—Neuronal System—HRAS—ovarian cancer	7.59e-05	0.000807	CbGpPWpGaD
Methylphenobarbital—GABRA4—Neuronal System—HRAS—ovarian cancer	7.49e-05	0.000797	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—BRIP1—ovarian cancer	7.35e-05	0.000781	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PPP1CC—ovarian cancer	7.35e-05	0.000781	CbGpPWpGaD
Methylphenobarbital—GABRA1—Transmission across Chemical Synapses—HRAS—ovarian cancer	7.15e-05	0.000761	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—MAPK1—ovarian cancer	6.83e-05	0.000726	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	6.81e-05	0.000725	CbGpPWpGaD
Methylphenobarbital—GABRA5—Neuronal System—HRAS—ovarian cancer	6.66e-05	0.000708	CbGpPWpGaD
Methylphenobarbital—GABRA3—Neuronal System—HRAS—ovarian cancer	6.54e-05	0.000695	CbGpPWpGaD
Methylphenobarbital—GABRA2—Neuronal System—HRAS—ovarian cancer	6.43e-05	0.000683	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYTB—ovarian cancer	6.35e-05	0.000675	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	6.21e-05	0.00066	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—BRIP1—ovarian cancer	5.55e-05	0.00059	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PPP1CC—ovarian cancer	5.55e-05	0.00059	CbGpPWpGaD
Methylphenobarbital—GABRA1—Neuronal System—HRAS—ovarian cancer	5.48e-05	0.000583	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—YAP1—ovarian cancer	4.93e-05	0.000524	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	4.04e-05	0.00043	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—FASN—ovarian cancer	4.02e-05	0.000427	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLC5A5—ovarian cancer	3.95e-05	0.00042	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—SLC2A1—ovarian cancer	3.82e-05	0.000406	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—YAP1—ovarian cancer	3.72e-05	0.000396	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	3.68e-05	0.000392	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CYP1B1—ovarian cancer	3.66e-05	0.000389	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PPP2R1A—ovarian cancer	3.24e-05	0.000345	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	3.24e-05	0.000344	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—FASN—ovarian cancer	3.03e-05	0.000323	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—ABCB1—ovarian cancer	3.01e-05	0.00032	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLC5A5—ovarian cancer	2.99e-05	0.000317	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—TYMS—ovarian cancer	2.96e-05	0.000315	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—SLC2A1—ovarian cancer	2.88e-05	0.000307	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	2.82e-05	0.0003	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CYP1B1—ovarian cancer	2.76e-05	0.000294	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PPP2R1A—ovarian cancer	2.45e-05	0.000261	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	2.44e-05	0.000259	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—CAV1—ovarian cancer	2.38e-05	0.000254	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—ABCB1—ovarian cancer	2.28e-05	0.000242	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—TYMS—ovarian cancer	2.24e-05	0.000238	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PIK3CG—ovarian cancer	2.17e-05	0.000231	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PIK3CD—ovarian cancer	1.91e-05	0.000203	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—CAV1—ovarian cancer	1.8e-05	0.000192	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.72e-05	0.000183	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PIK3CB—ovarian cancer	1.66e-05	0.000177	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PIK3CG—ovarian cancer	1.64e-05	0.000174	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PIK3CD—ovarian cancer	1.44e-05	0.000153	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PTEN—ovarian cancer	1.44e-05	0.000153	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PIK3CB—ovarian cancer	1.26e-05	0.000134	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PTEN—ovarian cancer	1.09e-05	0.000116	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—PIK3CA—ovarian cancer	1.01e-05	0.000108	CbGpPWpGaD
Methylphenobarbital—CYP2B6—Metabolism—AKT1—ovarian cancer	8.29e-06	8.81e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—PIK3CA—ovarian cancer	7.66e-06	8.15e-05	CbGpPWpGaD
Methylphenobarbital—CYP2C19—Metabolism—AKT1—ovarian cancer	6.26e-06	6.66e-05	CbGpPWpGaD
